CI Society

Vision

To cure Primary Immunodeficiency Disease, (PID).

back to top

Mission

Our mission is to improve the lives of people with Primary Immune Deficiency (PID) by promoting early diagnosis and effective treatments and through leadership in research, education and advocacy in partnership with healthcare professionals, volunteers, industry and government.

back to top

Our Values

These serve as our guidelines as we work in implementing our Vision:

• Equal access to all Canadians

• Dignity and respect for all individuals – We believe that all people should be treated with consideration. We appreciate diversity

• Accountability – We are committed to using donors’ dollars wisely

• Commitment to communities – We will nurture effective partnerships with volunteers, staff and other organizations

• Optimism –We believe that any challenges can be overcome with hope and determination

back to top

History

The Society was founded in 1999 by John Perl, whose child was diagnosed with severe combined immunodeficiency (SCID), Jay Lefton, philanthropist and partner at Aird & Berlis, and Dr. Chaim Roifman, Division Chief of Immunology/Allergy at the Hospital for Sick Children in Toronto, Canada. The CI Society plays a vital role in being one of the first organizations in Canada to support research in the field of primary immunodeficiency as well as supporting education of patients and medical professionals.

Board Members:

John F. Perl, President
Chaim Roifman, MD, FRCPC, Chair & Scientific Director
Peter Clark
Thomas Moran
Barry Reichmann
Joseph Vital

Executive Director:

Richard Thompson, CFRE

Corporate Advisory Board:

Joel Abelson, Vice President, Canada and Intercontinental Business, Talecris Biotherapeutics
Vicki Modell, Co-founder, Jeffrey Modell Foundation
Paul R. Perreault, Sr., Vice President & General Manager of North America Commercial Operations, CSL Behring

back to top